**Sally Rooney Faces Publishing Challenges Due to Palestine Action Ban**
Irish author Sally Rooney has expressed concerns in the High Court about her ability to publish new works in the UK and the potential withdrawal of her existing titles from sale due to the ban on Palestine Action. This legal action stems from the group’s co-founder, Huda Ammori, who is challenging the Home Office’s decision to classify Palestine Action as a terrorist organization under anti-terror laws enacted in July. The designation criminalizes membership or support for the group, with penalties of up to 14 years in prison.
In August, Rooney was cautioned that her intention to donate earnings from her books and the television adaptations of “Normal People” and “Conversations With Friends” to Palestine Action could be construed as a terrorist offense. In a witness statement released on Thursday, she revealed that the producer of the BBC adaptations informed her that they could not transfer funds to her agent if there was a possibility that the money would support Palestine Action, as this would violate anti-terror laws.
Rooney noted the uncertainty surrounding whether any UK company could legally pay her, stating that if she were barred from profiting from her work, her income would be “enormously restricted.” She emphasized that the publication of her books relies on royalties from sales, and if her publisher, Faber and Faber Limited, is legally prohibited from paying her royalties, her existing works might need to be withdrawn from sale, limiting access for readers in the UK. Rooney described this situation as “a truly extreme incursion by the state into the realm of artistic expression.”
She further asserted that it is “almost certain” she cannot publish or produce new creative works in the UK while the ban on Palestine Action remains in effect.
**FAQ**
*What is the impact of the Palestine Action ban on Sally Rooney’s work?*
The ban may prevent Rooney from publishing new works or receiving royalties from her existing titles, potentially leading to their withdrawal from sale in the UK.